Akter Sraboni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akter Sraboni has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Mannan Kazi Abdul
Center for Academic & Professional Career Development and Research (CAPCDR)
8 shared publications - Farhana Khandaker Mursheda
Shanto-Mariam University of Creative Technology
5 shared publications - Atifa Akter Juthy
Shanto-Mariam University of Creative Technology, Bangladesh
3 shared publications - Jannat Mst. Tahsina
Shanto-Mariam University of Creative Technology, Bangladesh
2 shared publications - Akter Yeasmin
Shanto-Mariam University of Creative Technology
1 shared publication - Huzaifa
Shanto-Mariam University of Creative Technology, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by MDPI AG in Preprints.org
Corporate Digital Responsibility and Sustainable Consumer Behaviour Toward Global Technology Platforms in Bangladesh: A Stakeholder-Centred Research Model
This study develops a stakeholder-centred explanation of how corporate digital responsibility (CDR) may relate to sustainable consumer behaviour in the context of global technology platforms in Bangladesh. Unlike group papers centred on adoption intention, privacy concern, trust or AI transparency, this article focuses on the responsibility-to-behaviour pathway: whether perceived responsible digital conduct is associated with consumers’ evaluation of firms’ obligations to users and society and with preferences for digital services that demonstrate socially responsible practices. The research plan specifies a quantitative, cross-sectional survey, a five-point Likert instrument, purposive eligibility screening and a target of 400 responses, with at least 385 usable cases. Stakeholder Theory, the Corporate Digital Responsibility framework and the Theory of Planned Behavior provide complementary conceptual lenses. The supplied workbook contains 385 populated records with complete values for the nine focal items. Exploratory composite means were 4.12 for CDR, 4.18 for perceived stakeholder responsibility (PSR), and 3.78 for sustainable consumer behaviour (SCB). However, preliminary Cronbach’s alpha estimates were only 0.33, 0.31, and 0.42, respectively, indicating that the current item sets do not demonstrate acceptable internal consistency. Simple regression diagnostics show positive associations, but these estimates are not treated as confirmatory hypothesis tests because measurement quality and data provenance remain unresolved. The paper therefore contributes a distinctive, testable framework and a transparent analysis pathway, while identifying the specific validation work required before empirical claims can be advanced.
- 16 October 2026
- Published by MDPI AG in Preprints.org
Open AccessCorporate Digital Responsibility and Sustainable Consumer Behaviour Toward Global Technology Platforms in Bangladesh: A Stakeholder-Centred Research Model
This study develops a stakeholder-centred explanation of how corporate digital responsibility (CDR) may relate to sustainable consumer behaviour in the context of global technology platforms in Bangladesh. Unlike group papers centred on adoption intention, privacy concern, trust or AI transparency, this article focuses on the responsibility-to-behaviour pathway: whether perceived responsible digital conduct is associated with consumers’ evaluation of firms’ obligations to users and society and with preferences for digital services that demonstrate socially responsible practices. The research plan specifies a quantitative, cross-sectional survey, a five-point Likert instrument, purposive eligibility screening and a target of 400 responses, with at least 385 usable cases. Stakeholder Theory, the Corporate Digital Responsibility framework and the Theory of Planned Behavior provide complementary conceptual lenses. The supplied workbook contains 385 populated records with complete values for the nine focal items. Exploratory composite means were 4.12 for CDR, 4.18 for perceived stakeholder responsibility (PSR), and 3.78 for sustainable consumer behaviour (SCB). However, preliminary Cronbach’s alpha estimates were only 0.33, 0.31, and 0.42, respectively, indicating that the current item sets do not demonstrate acceptable internal consistency. Simple regression diagnostics show positive associations, but these estimates are not treated as confirmatory hypothesis tests because measurement quality and data provenance remain unresolved. The paper therefore contributes a distinctive, testable framework and a transparent analysis pathway, while identifying the specific validation work required before empirical claims can be advanced.
- Open Access
- 9 October 2026
- Published by Elsevier in SSRN Electronic Journal
Digital Trust and Consumer Adoption of AI-Enabled Services Offered by Global Technology Companies in Bangladesh: An Empirical Analysis
As global technology companies embed artificial intelligence within search, communication, productivity, cloud, commerce and content services, consumer adoption increasingly depends on more than functional utility. This study develops and tests a trust-augmented Technology Acceptance Model to explain adoption intention among users of global digital platforms in Bangladesh. A quantitative cross-sectional survey was employed. Of the 400 targeted responses, 385 complete cases passed the embedded attention check and were retained for analysis. Perceived usefulness, perceived ease of use, digital trust and adoption intention were measured using three-item five-point Likert composites. Given modest internal consistency of the short scales, the study uses transparent composite-score regression rather than overstating latent-variable precision. Perceived ease of use positively predicted perceived usefulness (b=0.264, p<.001). In the adoption model, perceived usefulness (b=0.108, p=.023), perceived ease of use (b=0.192, p<.001) and digital trust (b=0.237, p<.001) each made significant positive contributions, jointly explaining 21.4% of variance in adoption intention. Standardized coefficients indicate that digital trust was the strongest of the three focal predictors (β=0.281), followed by ease of use (β=0.208) and usefulness (β=0.113). The findings extend TAM by showing that adoption in an AIenabled platform ecosystem is simultaneously instrumental and relational: consumers value usable and useful services, but confidence in established providers adds distinct explanatory power. The article contributes emerging-market evidence from Bangladesh while identifying measurement improvements required for stronger confirmatory testing in future research.
- 9 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDigital Trust and Consumer Adoption of AI-Enabled Services Offered by Global Technology Companies in Bangladesh: An Empirical Analysis
As global technology companies embed artificial intelligence within search, communication, productivity, cloud, commerce and content services, consumer adoption increasingly depends on more than functional utility. This study develops and tests a trust-augmented Technology Acceptance Model to explain adoption intention among users of global digital platforms in Bangladesh. A quantitative cross-sectional survey was employed. Of the 400 targeted responses, 385 complete cases passed the embedded attention check and were retained for analysis. Perceived usefulness, perceived ease of use, digital trust and adoption intention were measured using three-item five-point Likert composites. Given modest internal consistency of the short scales, the study uses transparent composite-score regression rather than overstating latent-variable precision. Perceived ease of use positively predicted perceived usefulness (b=0.264, p<.001). In the adoption model, perceived usefulness (b=0.108, p=.023), perceived ease of use (b=0.192, p<.001) and digital trust (b=0.237, p<.001) each made significant positive contributions, jointly explaining 21.4% of variance in adoption intention. Standardized coefficients indicate that digital trust was the strongest of the three focal predictors (β=0.281), followed by ease of use (β=0.208) and usefulness (β=0.113). The findings extend TAM by showing that adoption in an AIenabled platform ecosystem is simultaneously instrumental and relational: consumers value usable and useful services, but confidence in established providers adds distinct explanatory power. The article contributes emerging-market evidence from Bangladesh while identifying measurement improvements required for stronger confirmatory testing in future research.
- Open Access
- 9 October 2026
- Published by MDPI AG in Preprints.org
Threat Appraisal Coping Appraisal and Secure Networking Intention Among Technology Users in Bangladesh: An Exploratory Survey Analysis
Protection motivation theory distinguishes perceived threat from evaluations of protective responses, but interpreting their relationships requires dependable measures. This exploratory cross-sectional study assessed measurement quality and appraisal-related associations with secure networking practice intention in 385 complete questionnaire records from Bangladesh. Threat appraisal, coping appraisal and intention were represented by their respective three-item means. Internal consistency, heterotrait–monotrait ratios and a bounded covariance diagnostic were examined before hierarchical regression with HC3 standard errors, 2,000 bootstrap resamples and ten-fold cross-validation. Threat appraisal was positively associated with intention (b = 0.233, 95% CI 0.138–0.328), as was coping appraisal (b = 0.347, 95% CI 0.254–0.440). The interaction was unsupported (b = 0.002, p = .981), and the additive model performed slightly better in held-out prediction. Measurement evidence was inadequate: Cronbach’s alpha ranged from .358 to .432, average variance extracted from .192 to .229, and all construct-pair HTMT ratios exceeded .90. The positive coefficients consequently describe associations among labelled observed scores and cannot establish distinct appraisal mechanisms. The contribution is an assessment of the mismatch between the proposed construct structure and the available indicators, together with a transparent comparison of additive and interactive specifications. Future studies should validate differentiated measures and examine observed protective behaviour before deriving intervention recommendations.
- 9 October 2026
- Published by MDPI AG in Preprints.org
Open AccessThreat Appraisal Coping Appraisal and Secure Networking Intention Among Technology Users in Bangladesh: An Exploratory Survey Analysis
Protection motivation theory distinguishes perceived threat from evaluations of protective responses, but interpreting their relationships requires dependable measures. This exploratory cross-sectional study assessed measurement quality and appraisal-related associations with secure networking practice intention in 385 complete questionnaire records from Bangladesh. Threat appraisal, coping appraisal and intention were represented by their respective three-item means. Internal consistency, heterotrait–monotrait ratios and a bounded covariance diagnostic were examined before hierarchical regression with HC3 standard errors, 2,000 bootstrap resamples and ten-fold cross-validation. Threat appraisal was positively associated with intention (b = 0.233, 95% CI 0.138–0.328), as was coping appraisal (b = 0.347, 95% CI 0.254–0.440). The interaction was unsupported (b = 0.002, p = .981), and the additive model performed slightly better in held-out prediction. Measurement evidence was inadequate: Cronbach’s alpha ranged from .358 to .432, average variance extracted from .192 to .229, and all construct-pair HTMT ratios exceeded .90. The positive coefficients consequently describe associations among labelled observed scores and cannot establish distinct appraisal mechanisms. The contribution is an assessment of the mismatch between the proposed construct structure and the available indicators, together with a transparent comparison of additive and interactive specifications. Future studies should validate differentiated measures and examine observed protective behaviour before deriving intervention recommendations.
- 2 October 2026
- Published by KMF Publishers in International Research Journal of Business and Social Science
- Vol. 12 (4) , 19
Data Privacy Concerns and Consumer Engagement with AI-Enabled Global Digital Platforms in Bangladesh: The Mediating Role of Perceived Trust
This study examines how data privacy concerns shape consumer engagement with AI-enabled global digital platforms in Bangladesh and tests perceived trust as an intervening mechanism. The study responds to the rapid normalization of data-intensive platform services in an emerging digital economy, where privacy concern, trust and continued participation coexist rather than operate as simple opposites. A quantitative cross-sectional survey design was used. Of 400 database rows, 385 complete cases passed the embedded attention check and were retained. Privacy concern, perceived trust and consumer engagement were measured with three five-point Likert items each. Composite-score regression and non-parametric bootstrap mediation were used as a transparent robustness-oriented analysis because the three-item scales displayed only modest internal consistency. Privacy concern was positively associated with trust (b=0.164, p=0.006); trust, in turn, was positively associated with engagement while controlling for privacy concern (b=0.231, p<.001). The total privacy-concern-engagement association was small but significant (b=0.117, p=0.026), whereas the direct effect became non-significant after trust entered the model (b=0.079, p=0.123). The bootstrapped indirect effect was 0.038, 95% CI [0.010, 0.072], indicating an indirect pathway through trust. These results reveal a contextually important privacy-trust-engagement configuration, but the modest reliability of the short scales requires cautious interpretation. The article therefore contributes both substantive evidence and a measurement lesson for platform research in Bangladesh: privacy salience may coexist with engagement when users retain confidence in established platforms, yet stronger validated measures are needed before definitive causal or theory-confirming claims are made. Keywords: privacy calculus; digital trust; consumer engagement; global digital platforms; artificial intelligence; Bangladesh; mediation
- 2 October 2026
- Published by KMF Publishers in International Research Journal of Business and Social Science
- Vol. 12 (4) , 19
Data Privacy Concerns and Consumer Engagement with AI-Enabled Global Digital Platforms in Bangladesh: The Mediating Role of Perceived Trust
This study examines how data privacy concerns shape consumer engagement with AI-enabled global digital platforms in Bangladesh and tests perceived trust as an intervening mechanism. The study responds to the rapid normalization of data-intensive platform services in an emerging digital economy, where privacy concern, trust and continued participation coexist rather than operate as simple opposites. A quantitative cross-sectional survey design was used. Of 400 database rows, 385 complete cases passed the embedded attention check and were retained. Privacy concern, perceived trust and consumer engagement were measured with three five-point Likert items each. Composite-score regression and non-parametric bootstrap mediation were used as a transparent robustness-oriented analysis because the three-item scales displayed only modest internal consistency. Privacy concern was positively associated with trust (b=0.164, p=0.006); trust, in turn, was positively associated with engagement while controlling for privacy concern (b=0.231, p<.001). The total privacy-concern-engagement association was small but significant (b=0.117, p=0.026), whereas the direct effect became non-significant after trust entered the model (b=0.079, p=0.123). The bootstrapped indirect effect was 0.038, 95% CI [0.010, 0.072], indicating an indirect pathway through trust. These results reveal a contextually important privacy-trust-engagement configuration, but the modest reliability of the short scales requires cautious interpretation. The article therefore contributes both substantive evidence and a measurement lesson for platform research in Bangladesh: privacy salience may coexist with engagement when users retain confidence in established platforms, yet stronger validated measures are needed before definitive causal or theory-confirming claims are made. Keywords: privacy calculus; digital trust; consumer engagement; global digital platforms; artificial intelligence; Bangladesh; mediation
- 25 July 2026
- Published by KMF Publishers in Migration Diaspora and Remittance Review
- Vol. 6 (3)
Water as Border: River Erosion, Climate Migration, and the Remapping of Social Identity
This article examines how climate-driven river erosion transforms belonging and social identity among displaced communities living in ecologically volatile regions. The study addresses the central problem of how water functions simultaneously as a material boundary and a symbolic force within climate migration. Grounded in political ecology and border studies, the analysis conceptualises shifting riverbanks as fluid borders that reorder territorial attachments, memory, and cultural meaning. Using qualitative methods-ethnographic fieldwork, narrative interviews, and community storytelling-the research documents lived experiences of loss, relocation, and identity reconstruction. The findings reveal that erosion produces hybrid and contested identities shaped by vulnerability, resilience, and ritual continuity. Displaced families reconfigure belonging through shared memory, symbolic relationships with water, and collective strategies of adaptation despite systemic exclusion in host settlements. The core claim is that water acts as an active participant in identity-making, extending border theory beyond territorial demarcation into affective and cultural realms. The study contributes to climate migration scholarship by offering a relational understanding of ecological change and by emphasising water’s agency in remapping social identities. Keywords: River Erosion, Climate Migration, Ritual Practices, Territorial Belonging, Identity Reconstruction, Vulnerability
- 25 July 2026
- Published by KMF Publishers in Migration Diaspora and Remittance Review
- Vol. 6 (3)
Water as Border: River Erosion, Climate Migration, and the Remapping of Social Identity
This article examines how climate-driven river erosion transforms belonging and social identity among displaced communities living in ecologically volatile regions. The study addresses the central problem of how water functions simultaneously as a material boundary and a symbolic force within climate migration. Grounded in political ecology and border studies, the analysis conceptualises shifting riverbanks as fluid borders that reorder territorial attachments, memory, and cultural meaning. Using qualitative methods-ethnographic fieldwork, narrative interviews, and community storytelling-the research documents lived experiences of loss, relocation, and identity reconstruction. The findings reveal that erosion produces hybrid and contested identities shaped by vulnerability, resilience, and ritual continuity. Displaced families reconfigure belonging through shared memory, symbolic relationships with water, and collective strategies of adaptation despite systemic exclusion in host settlements. The core claim is that water acts as an active participant in identity-making, extending border theory beyond territorial demarcation into affective and cultural realms. The study contributes to climate migration scholarship by offering a relational understanding of ecological change and by emphasising water’s agency in remapping social identities. Keywords: River Erosion, Climate Migration, Ritual Practices, Territorial Belonging, Identity Reconstruction, Vulnerability
- 13 March 2026
- Published by KMF Publishers in Journal of Pandemic Disaster and Recession
- Vol. 6 (1)
Artificial Intelligence and Digital Health Technologies in Pandemic and Disaster Management: Opportunities and Challenges
The increasing frequency of global pandemics and large-scale disasters has highlighted the urgent need for innovative technological solutions to strengthen healthcare systems and improve crisis response mechanisms. Artificial intelligence (AI) and digital health technologies, such as telemedicine, big data analytics, mobile health (mHealth), wearable devices, and digital surveillance systems, have emerged as transformative tools in modern healthcare governance. This study examines the role of AI and digital health technologies in pandemic and disaster management, focusing on their opportunities, challenges, and implications for resilient healthcare systems. Using a qualitative research design grounded in secondary data analysis, the study reviews scholarly literature, policy reports, and case studies on the use of digital technologies during global health emergencies, particularly the COVID-19 pandemic. The findings indicate that AI-driven analytics significantly enhance disease surveillance, predictive modelling, and evidence-based decision-making, while telemedicine and mobile health technologies improve healthcare accessibility during crises. At the same time, the study identifies several critical challenges, including data privacy concerns, cybersecurity risks, algorithmic bias, and technological inequalities associated with the digital divide. Drawing on sociotechnical systems theory, resilience theory, and insights from Qur’anic research methodology, the study emphasises the need for ethical governance and inclusive technological development. The research concludes that effective integration of AI and digital health technologies requires robust regulatory frameworks, improved digital infrastructure, and equitable access to technological resources. By addressing these issues, digital health innovations can play a vital role in strengthening global preparedness for future pandemics and disasters. Keywords: Artificial Intelligence, Digital Health Technologies, Pandemic Management, Disaster Governance, Telemedicine, Health System Resilience
- 13 March 2026
- Published by KMF Publishers in Journal of Pandemic Disaster and Recession
- Vol. 6 (1)
Artificial Intelligence and Digital Health Technologies in Pandemic and Disaster Management: Opportunities and Challenges
The increasing frequency of global pandemics and large-scale disasters has highlighted the urgent need for innovative technological solutions to strengthen healthcare systems and improve crisis response mechanisms. Artificial intelligence (AI) and digital health technologies, such as telemedicine, big data analytics, mobile health (mHealth), wearable devices, and digital surveillance systems, have emerged as transformative tools in modern healthcare governance. This study examines the role of AI and digital health technologies in pandemic and disaster management, focusing on their opportunities, challenges, and implications for resilient healthcare systems. Using a qualitative research design grounded in secondary data analysis, the study reviews scholarly literature, policy reports, and case studies on the use of digital technologies during global health emergencies, particularly the COVID-19 pandemic. The findings indicate that AI-driven analytics significantly enhance disease surveillance, predictive modelling, and evidence-based decision-making, while telemedicine and mobile health technologies improve healthcare accessibility during crises. At the same time, the study identifies several critical challenges, including data privacy concerns, cybersecurity risks, algorithmic bias, and technological inequalities associated with the digital divide. Drawing on sociotechnical systems theory, resilience theory, and insights from Qur’anic research methodology, the study emphasises the need for ethical governance and inclusive technological development. The research concludes that effective integration of AI and digital health technologies requires robust regulatory frameworks, improved digital infrastructure, and equitable access to technological resources. By addressing these issues, digital health innovations can play a vital role in strengthening global preparedness for future pandemics and disasters. Keywords: Artificial Intelligence, Digital Health Technologies, Pandemic Management, Disaster Governance, Telemedicine, Health System Resilience
- 12 January 2026
- Published by KMF Publishers in Journal of Biochemistry Pharmacology and Public Health
- Vol. 4 (1)
Biochemical and Pharmacological Mechanisms of GLP-1 and Dual Agonists: Implications for Glycemic Control and Cardiovascular Risk Reduction — A Review
Glucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin agonists, particularly glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor co-agonists, represent a major therapeutic advancement in the management of type 2 diabetes mellitus (T2DM) and obesity. Beyond glycemic control, these agents demonstrate clinically significant benefits in weight reduction, blood pressure modulation, lipid profile improvement, and cardiovascular risk mitigation. This review synthesises biochemical, molecular, and pharmacological mechanisms underlying the clinical effectiveness of GLP-1 receptor agonists and dual agonists such as semaglutide and tirzepatide. Guided by a translational biomedical framework integrating receptor signalling theory and cardiometabolic risk models, this qualitative systematic narrative review evaluates peer-reviewed literature on metabolic pathways, neuroendocrine signalling, inflammatory modulation, and endothelial function. Findings suggest that dual agonists provide additive and potentially synergistic metabolic benefits through complementary receptor activation, enhancing insulin sensitivity, appetite regulation, and vascular protection. The review highlights implications for cardiovascular disease prevention, therapeutic guidelines, and future drug development. Limitations include heterogeneity in clinical trial populations and evolving long-term safety data. Future research should prioritise mechanistic human studies, real-world cardiovascular outcomes, and equity in drug access. Keywords: GLP-1 receptor agonists, dual incretin agonists, tirzepatide, semaglutide, cardiovascular risk, type 2 diabetes, obesity, pharmacology
- 12 January 2026
- Published by KMF Publishers in Journal of Biochemistry Pharmacology and Public Health
- Vol. 4 (1)
Biochemical and Pharmacological Mechanisms of GLP-1 and Dual Agonists: Implications for Glycemic Control and Cardiovascular Risk Reduction — A Review
Glucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin agonists, particularly glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor co-agonists, represent a major therapeutic advancement in the management of type 2 diabetes mellitus (T2DM) and obesity. Beyond glycemic control, these agents demonstrate clinically significant benefits in weight reduction, blood pressure modulation, lipid profile improvement, and cardiovascular risk mitigation. This review synthesises biochemical, molecular, and pharmacological mechanisms underlying the clinical effectiveness of GLP-1 receptor agonists and dual agonists such as semaglutide and tirzepatide. Guided by a translational biomedical framework integrating receptor signalling theory and cardiometabolic risk models, this qualitative systematic narrative review evaluates peer-reviewed literature on metabolic pathways, neuroendocrine signalling, inflammatory modulation, and endothelial function. Findings suggest that dual agonists provide additive and potentially synergistic metabolic benefits through complementary receptor activation, enhancing insulin sensitivity, appetite regulation, and vascular protection. The review highlights implications for cardiovascular disease prevention, therapeutic guidelines, and future drug development. Limitations include heterogeneity in clinical trial populations and evolving long-term safety data. Future research should prioritise mechanistic human studies, real-world cardiovascular outcomes, and equity in drug access. Keywords: GLP-1 receptor agonists, dual incretin agonists, tirzepatide, semaglutide, cardiovascular risk, type 2 diabetes, obesity, pharmacology
- 12 January 2026
- Published by KMF Publishers in Journal of Biotechnology and Food Engineering
- Vol. 4 (1)
Future Prospects of GLP-1–Based Biopharmaceuticals in Obesity and Diabetes Management: A Food and Biotechnology Perspective
The global rise in obesity and type 2 diabetes has intensified interest in glucagon-like peptide-1 (GLP-1)–based biopharmaceuticals as transformative metabolic therapies. While these agents demonstrate substantial efficacy in glycemic control, weight reduction, and cardiovascular risk mitigation, their long-term population-level impact depends on broader behavioural, food system, and policy contexts. This study explores the prospects of GLP-1–based therapies from an integrated food and biotechnology perspective using a qualitative research design. Semi-structured interviews were conducted with experts in endocrinology, nutrition science, biotechnology, and public health policy, followed by thematic analysis. Findings indicate that technological innovation—such as oral formulations and multi-agonist molecules—may improve scalability and patient acceptance, but sustainable outcomes require concurrent dietary quality improvement, supportive food environments, and healthcare system integration. Participants emphasised that pharmacotherapy facilitates but does not replace behavioural change and that inequitable access and regulatory fragmentation remain major barriers. The study concludes that GLP-1–based biopharmaceuticals should be embedded within interdisciplinary metabolic health strategies that align pharmaceutical innovation with nutrition policy and food system reform. Such alignment is essential for achieving durable and equitable reductions in metabolic disease burden worldwide. Keywords: GLP-1 receptor agonists; obesity mana
- 12 January 2026
- Published by KMF Publishers in Journal of Biotechnology and Food Engineering
- Vol. 4 (1)
Future Prospects of GLP-1–Based Biopharmaceuticals in Obesity and Diabetes Management: A Food and Biotechnology Perspective
The global rise in obesity and type 2 diabetes has intensified interest in glucagon-like peptide-1 (GLP-1)–based biopharmaceuticals as transformative metabolic therapies. While these agents demonstrate substantial efficacy in glycemic control, weight reduction, and cardiovascular risk mitigation, their long-term population-level impact depends on broader behavioural, food system, and policy contexts. This study explores the prospects of GLP-1–based therapies from an integrated food and biotechnology perspective using a qualitative research design. Semi-structured interviews were conducted with experts in endocrinology, nutrition science, biotechnology, and public health policy, followed by thematic analysis. Findings indicate that technological innovation—such as oral formulations and multi-agonist molecules—may improve scalability and patient acceptance, but sustainable outcomes require concurrent dietary quality improvement, supportive food environments, and healthcare system integration. Participants emphasised that pharmacotherapy facilitates but does not replace behavioural change and that inequitable access and regulatory fragmentation remain major barriers. The study concludes that GLP-1–based biopharmaceuticals should be embedded within interdisciplinary metabolic health strategies that align pharmaceutical innovation with nutrition policy and food system reform. Such alignment is essential for achieving durable and equitable reductions in metabolic disease burden worldwide. Keywords: GLP-1 receptor agonists; obesity mana
- 12 January 2026
- Published by KMF Publishers in Public Healthcare and Ancient Science
- Vol. 6 (1)
Integrating Modern GLP-1–Based Therapies with Traditional Lifestyle Interventions: A Public Health Review on Diabetes and Obesity Management
The global prevalence of obesity and type 2 diabetes mellitus (T2DM) has reached unprecedented levels, posing significant challenges to health systems, particularly in low- and middle-income countries. While traditional lifestyle interventions-dietary modification, physical activity, and behavioural change-remain foundational in prevention and management strategies, their long-term effectiveness has been limited by biological, social, and structural constraints. In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin-based therapies have emerged as transformative pharmacological tools, demonstrating substantial efficacy in glycemic control, weight reduction, and cardiometabolic risk mitigation. This public health review critically examines the integration of modern GLP-1–based therapies with traditional lifestyle interventions, emphasising synergy rather than substitution. Using a qualitative methodology grounded in narrative synthesis and policy analysis, the study draws upon clinical trials, public health guidelines, and sociobehavioral research to explore effectiveness, equity, ethical considerations, and implementation challenges. A socioecological and chronic care theoretical framework is employed to contextualise obesity and diabetes as complex, multifactorial conditions requiring sustained, system-level responses. The review argues that GLP-1 therapies, when embedded within comprehensive lifestyle and public health strategies, offer a more realistic and equitable pathway for long-term disease management. However, issues of access, affordability, cultural adaptation, and health system capacity remain critical barriers. The article concludes with policy-oriented recommendations for integrating pharmacotherapy and lifestyle interventions in a manner that strengthens public health outcomes while minimising inequities. Keywords: GLP-1 receptor agonists, obesity, type 2 diabetes, lifestyle intervention, public health, qualitative review
- 12 January 2026
- Published by KMF Publishers in Public Healthcare and Ancient Science
- Vol. 6 (1)
Integrating Modern GLP-1–Based Therapies with Traditional Lifestyle Interventions: A Public Health Review on Diabetes and Obesity Management
The global prevalence of obesity and type 2 diabetes mellitus (T2DM) has reached unprecedented levels, posing significant challenges to health systems, particularly in low- and middle-income countries. While traditional lifestyle interventions-dietary modification, physical activity, and behavioural change-remain foundational in prevention and management strategies, their long-term effectiveness has been limited by biological, social, and structural constraints. In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin-based therapies have emerged as transformative pharmacological tools, demonstrating substantial efficacy in glycemic control, weight reduction, and cardiometabolic risk mitigation. This public health review critically examines the integration of modern GLP-1–based therapies with traditional lifestyle interventions, emphasising synergy rather than substitution. Using a qualitative methodology grounded in narrative synthesis and policy analysis, the study draws upon clinical trials, public health guidelines, and sociobehavioral research to explore effectiveness, equity, ethical considerations, and implementation challenges. A socioecological and chronic care theoretical framework is employed to contextualise obesity and diabetes as complex, multifactorial conditions requiring sustained, system-level responses. The review argues that GLP-1 therapies, when embedded within comprehensive lifestyle and public health strategies, offer a more realistic and equitable pathway for long-term disease management. However, issues of access, affordability, cultural adaptation, and health system capacity remain critical barriers. The article concludes with policy-oriented recommendations for integrating pharmacotherapy and lifestyle interventions in a manner that strengthens public health outcomes while minimising inequities. Keywords: GLP-1 receptor agonists, obesity, type 2 diabetes, lifestyle intervention, public health, qualitative review
- 12 January 2026
- Published by KMF Publishers in Review of Medicine Surgery and Dentistry
- Vol. 5 (1)
Emerging Role of Dual Agonists in Metabolic Disease Management: Clinical Outcomes and Safety Considerations – A Review Study
Metabolic diseases, including type 2 diabetes mellitus (T2DM) and obesity, represent interconnected chronic conditions driven by complex neuroendocrine and metabolic dysregulation. Recent pharmacological advances have introduced dual incretin receptor agonists that simultaneously target glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) pathways, offering enhanced therapeutic potential beyond conventional mono-agonist therapies. This review synthesises qualitative thematic evidence from major clinical trials, mechanistic studies, and real-world observational research to evaluate the clinical effectiveness and safety considerations of dual agonists in metabolic disease management. Guided by neuroendocrine integration theory, metabolic flexibility frameworks, and chronic disease systems models, the review explores how dual agonists improve glycemic control, promote substantial weight loss, and modify cardiometabolic risk factors. Thematic synthesis indicates that synergistic hormonal modulation enhances appetite regulation, insulin sensitivity, and adipose tissue remodelling, while adverse effects remain largely gastrointestinal and manageable through dose-escalation strategies. Policy implications regarding cost, access, and preventive pharmacotherapy are discussed alongside biotechnology innovations such as multi-agonist drug design and personalised metabolic medicine. Overall, dual agonists represent a transformative therapeutic class with significant implications for integrated metabolic disease management. Keywords: Dual agonists; GLP-1; GIP; metabolic disease; obesity; type 2 diabetes; incretin therapy
- 12 January 2026
- Published by KMF Publishers in Review of Medicine Surgery and Dentistry
- Vol. 5 (1)
Emerging Role of Dual Agonists in Metabolic Disease Management: Clinical Outcomes and Safety Considerations – A Review Study
Metabolic diseases, including type 2 diabetes mellitus (T2DM) and obesity, represent interconnected chronic conditions driven by complex neuroendocrine and metabolic dysregulation. Recent pharmacological advances have introduced dual incretin receptor agonists that simultaneously target glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) pathways, offering enhanced therapeutic potential beyond conventional mono-agonist therapies. This review synthesises qualitative thematic evidence from major clinical trials, mechanistic studies, and real-world observational research to evaluate the clinical effectiveness and safety considerations of dual agonists in metabolic disease management. Guided by neuroendocrine integration theory, metabolic flexibility frameworks, and chronic disease systems models, the review explores how dual agonists improve glycemic control, promote substantial weight loss, and modify cardiometabolic risk factors. Thematic synthesis indicates that synergistic hormonal modulation enhances appetite regulation, insulin sensitivity, and adipose tissue remodelling, while adverse effects remain largely gastrointestinal and manageable through dose-escalation strategies. Policy implications regarding cost, access, and preventive pharmacotherapy are discussed alongside biotechnology innovations such as multi-agonist drug design and personalised metabolic medicine. Overall, dual agonists represent a transformative therapeutic class with significant implications for integrated metabolic disease management. Keywords: Dual agonists; GLP-1; GIP; metabolic disease; obesity; type 2 diabetes; incretin therapy